Y-mAbs Therapeutics, Inc. (YMAB) Balance Sheet Quarterly

Y-mAbs Therapeutics, Inc.

YMAB (NASDAQ)

(%)

Financials
Y-mAbs Therapeutics, Inc. Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2025 (Q2) 06-30	2025 (Q1) 03-31	2024 (Q4) 12-31	2024 (Q3) 09-30	2024 (Q2) 06-30	2024 (Q1) 03-31	2023 (Q4) 12-31
Report Filing:	2025-08-08	2025-05-13	2025-03-04	2024-11-08	2024-08-12	2024-05-07	1234
Total Current Assets	91.79	90.45	98.51	99.06	126.8	108.3	1234
Cash and Short Term Investments	62.29	60.31	67.23	68.12	77.81	75.75	1234
Cash & Equivalents	62.29	60.31	67.23	68.12	77.81	75.75	1234
Short Term Investments	0	0	0	0	0	0	1234
Receivables	15.74	17.74	19.69	19.92	38.22	20.59	1234
Inventory	9.72	8	7.21	9.56	8.5	8.45	1234
Other Current Assets	4.04	4.4	4.37	1.46	2.24	3.48	1234
Total Assets	117.2	112.6	119.9	120.9	144	123.3	1234
Total Non-Current Assets	25.42	22.16	21.39	21.86	17.27	15.05	1234
Property, Plant and Equipment	3.38	0.762	0.859	1.13	1.36	1.33	1234
Goodwill and Intangible Assets	2.18	2.21	2.28	2.37	2.45	2.54	1234
Goodwill	0	0	0	0	0	0	1234
Intangible Assets	2.18	2.21	2.28	2.37	2.45	2.54	1234
Long Term Investments	0	0	0	0	0	0	1234
Deferred Tax Assets	0	0	0	0	0	0	1234
Other Long Term Assets	19.87	19.19	18.26	18.37	13.46	11.17	1234
Total Current Liabilities	22.95	18.96	23.7	25.29	43.47	17.61	1234
Accounts Payable	7.57	4.63	6.66	7.88	10.19	6.73	1234
Notes Payable/Short Term Debt	0.486	0.455	0.63	0.776	0.842	1.78	1234
Tax Payables	0	0	0	0	0	0	1234
Deferred Revenue	0	0	0	0	0	0	1234
Other Current Liabilities	14.89	13.88	16.41	16.64	32.44	9.1	1234
Total Liabilities	29.72	23.16	27.9	28.49	48.7	24.13	1234
Total Non-Current Liabilities	6.77	4.2	4.2	3.2	5.23	6.52	1234
Total Long Term Debt	2.64	0.148	0.19	0.299	0.432	0.293	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	0	0	0	0	0	0	1234
Capital Lease Obligations	0	0.603	0.82	1.07	1.27	1.18	1234
Other Long Term Liabilities	4.13	3.45	3.19	1.82	3.52	5.05	1234
Total Equity	87.49	89.46	92	92.43	95.34	99.19	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	87.49	89.46	92	92.43	95.34	99.19	1234
Retained Earnings	-495.6	-492.3	-487.1	-480.3	-473.3	-464.1	1234
Accumulated Other Earnings	-0.612	1.4	2.26	-0.036	1.05	0.848	1234
Common Stock	0.005	0.005	0.004	0.004	0.004	0.004	1234
Preferred Stock	0	0	0	0	0	0	1234
Additional Paid in Capital	583.7	580.4	576.9	572.8	567.6	562.4	1234
Total Liabilities & Total Equity	117.2	112.6	119.9	120.9	144	123.3	1234
Total Liabilities & Shareholders' Equity	117.2	112.6	119.9	120.9	144	123.3	1234
Total Investments	0	0	0	0	0	0	1234
Total Debt	3.12	0.603	0.82	1.07	1.27	1.18	1234
Net Debt	-59.17	-59.71	-66.41	-67.05	-76.53	-74.57	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Y-mAbs Therapeutics, Inc. Balance Sheet Statement Quarterly